Uniting ACOs With DNA
Quibble Genomics - Uniting ACOs with the DNA Analysis Ecosystem
Genomics testing will help account care organizations (ACOs) and other forward-thinking healthcare providers create outreach programs that will improve member health and lower costs. What these organizations need is a way for patients to have their DNA tested efficiently and cost effectively.
Unfortunately, there are only a few specialized labs across the globe equipped to perform specialized DNA diagnostics and determining the appropriate provider can be a costly and painstaking process.
Quibble Genomics is Changing the Dynamic
“A physician can go to the Quibble site and find any genetic panel test available to order,” said Dr. Rao Kotamarti, CEO of Quibble Genomics. “Just like a cholesterol screening, there’s no question in a physician’s mind how to get it done and how much it costs. We call it solving the ‘last mile’ problem.”
The way current laboratory screenings work is a patient gives a sample and then most tests are conducted onsite. An example is a cholesterol screening where a clinician draws blood and the results are generated within minutes. It’s a model that requires a broad distribution of equipment and testing locations.
It’s also a model that simply will not work when it comes to DNA testing for two reasons:
- The equipment required to run a DNA analysis is extremely expensive.
- It can take up to seven days to run a single test.
So, to perform cost-effective, efficient DNA analysis requires a paradigm shift in laboratory testing.
DNA Analysis: Lowering Cost & Improving Efficiency
Quibble solves the first issue by facilitating communication between providers and genomics labs. The expensive equipment remains centralized, and Quibble makes it easy for providers to find the perfect lab for their desired test.
“We’re building an ecosystem,” said Dr. Kotamarti, “where we have clusters of labs that perform highly specialized tests very efficiently. Now, the infrastructure that is required ensures that no single company can do that. However, an ecosystem can do it really well and Quibble connects the dots.”
As for the second issue – that it can take days to run a DNA analysis – Quibble actually sees that as an advantage.
“The way you set up a DNA analysis job is you either set up a big job or you can set up many small jobs. Let’s use a test for pancreatic cancer as an example. Say each test accounts for about 20 genes or so, but the capacity of a machine may be 1000 genes that it can sequence at a time. That means I can get about 50 samples processed in the same run of that machine. There is an optimum point where the economy of scale actually helps lower the per sample cost. Additionally, the amount of materials needed to operate these sequencing machines also comes down. So, that volume advantage plays out handsomely both in cost of materials and also running the machine.”
Once a DNA analysis is performed, Quibble also serves this ecosystem as a cloud-based data repository – and the information is constantly being updated with the latest scientific discoveries.
Early Adopters See the Biggest Benefits
As the volume of genomics data grows and researchers make new discoveries of how diseases relate to specific genes, diagnostic testing and medications will evolve rapidly. Providers who are the first on board will see the biggest benefit as genomics revolutionizes and personalizes healthcare.
“We are different from other service providers because Quibble doesn't solve just the reachability problem, our focus is on making the genomic data from clinical and non clinical tests useful for self analysis and taking an action that makes sense for the patient,” said Dr. Kotamarti. “Quibble does this by aggregating genomic data into a holistic digital human that a patient or a provider can view and also utilize for timely alerts and actions as new information emerges.”
This wealth of genetic information coupled with easy access to testing means Quibble creates an upward slope for performance over time, patients, and tests.
“An organization like an ACO is perfectly aligned to utilize the convenience that Quibble offers,” said Dr. Kotamarti. “The way an ACO is designed, they can take DNA analysis from one patient population or set of physicians and spread it across the entire organization, replicating the success of one practice area to physicians throughout the network.
“The purpose of all testing is to provide treatment as quickly as possible. And the purpose of all treatment is to reduce healthcare costs down the road. By successfully reducing healthcare costs, you have a healthy, managed patient population that meets the goals for the ACO.”
There has been a rapid adoption of genomics, but it’s only a slight indication of what’s to come. By bridging the few specialized labs across the globe equipped to perform specialized DNA diagnostics, Quibble is helping to create and connect this ecosystem as it evolves and advances.
“Genomics is an emerging need in an emerging ecosystem,” said Dr. Kotamarti. “We’ve taken the most efficient sample collection distribution possible and the most efficient lab processing that is there for genetic testing and bridged the two. We’re providing an opportunity for hospitals and physicians to be able to offer DNA testing with ease and confidence.”
To discover more about Quibble Genomics and its role in the DNA ecosystem, click here.